v3.25.4
Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Nov. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss attributable to common stockholders $ (71,067) $ (203,495) $ (86,097)  
Denominator for basic net loss per share — weighted-average shares (in shares) [1] 28,304,000 28,286,000 28,280,000  
Effect of dilutive securities:        
Unvested restricted shares (in shares) 16,000 0 21,000  
Common OP Units (in shares) 124,000 124,000 124,000  
Class B Units (in shares) 110,000 110,000 110,000  
Denominator for diluted net loss per share — weighted-average shares (in shares) 28,554,000 28,520,000 28,535,000  
Basic net loss per share (in usd per share) [1] $ (2.51) $ (7.19) $ (3.04)  
Diluted net loss per share (in usd per share) [1] $ (2.51) $ (7.19) $ (3.04)  
Limited partner units (in shares) 405,998     405,908
Class B units (in shares) 359,250 359,250 359,250  
Advisor | American Realty Capital Healthcare III Advisors, LLC        
Effect of dilutive securities:        
Limited partner units (in shares) 405,998 405,998 405,998  
Unvested restricted Shares        
Effect of dilutive securities:        
Unvested restricted stock (in shares) 160,199 0 12,911  
[1] Retroactively adjusted for the effects of previous stock dividends (see Note 1 — Organization ). Potential common shares are not included in the computation of diluted earnings per share (“EPS”) when a net loss exists as the effect would be an antidilutive per share amount.